MXPA02002864A - Secuencias de arn de auto- escision y su uso para el control de sintesis de proteinas. - Google Patents

Secuencias de arn de auto- escision y su uso para el control de sintesis de proteinas.

Info

Publication number
MXPA02002864A
MXPA02002864A MXPA02002864A MXPA02002864A MXPA02002864A MX PA02002864 A MXPA02002864 A MX PA02002864A MX PA02002864 A MXPA02002864 A MX PA02002864A MX PA02002864 A MXPA02002864 A MX PA02002864A MX PA02002864 A MXPA02002864 A MX PA02002864A
Authority
MX
Mexico
Prior art keywords
control
protein synthesis
rna sequences
cleaving rna
self cleaving
Prior art date
Application number
MXPA02002864A
Other languages
English (en)
Inventor
Vincent Thuillier
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA02002864A publication Critical patent/MXPA02002864A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1048—SELEX
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MXPA02002864A 1999-10-15 2000-10-13 Secuencias de arn de auto- escision y su uso para el control de sintesis de proteinas. MXPA02002864A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99402552A EP1092777A1 (en) 1999-10-15 1999-10-15 Self-cleaving RNA sequences and their use for the control of protein synthesis.
PCT/EP2000/010423 WO2001029234A2 (en) 1999-10-15 2000-10-13 Self-cleaving rna sequences and their use for the control of protein synthesis

Publications (1)

Publication Number Publication Date
MXPA02002864A true MXPA02002864A (es) 2003-07-21

Family

ID=8242144

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02002864A MXPA02002864A (es) 1999-10-15 2000-10-13 Secuencias de arn de auto- escision y su uso para el control de sintesis de proteinas.

Country Status (16)

Country Link
EP (2) EP1092777A1 (es)
JP (1) JP2003512059A (es)
KR (1) KR20020037384A (es)
CN (1) CN1377414A (es)
AU (1) AU784832B2 (es)
BR (1) BR0014632A (es)
CA (1) CA2387185A1 (es)
CZ (1) CZ20021313A3 (es)
HU (1) HUP0203268A3 (es)
IL (1) IL148572A0 (es)
MX (1) MXPA02002864A (es)
NO (1) NO20021713L (es)
NZ (1) NZ518396A (es)
PL (1) PL355165A1 (es)
WO (1) WO2001029234A2 (es)
ZA (1) ZA200202823B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858390B2 (en) 1998-12-31 2005-02-22 Ingeneus Corporation Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
CN108350451A (zh) * 2015-11-12 2018-07-31 贝勒医学院 通过适体介导的多腺苷酸化调节来外源性控制哺乳动物基因表达
JP2022507269A (ja) * 2018-11-13 2022-01-18 オンコラス， インコーポレイテッド カプセル化ポリヌクレオチド及び使用方法
CN116555253A (zh) * 2022-01-30 2023-08-08 中国科学院分子细胞科学卓越创新中心 含高均一性poly(A)尾的mRNA及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013791A1 (en) * 1992-12-04 1994-06-23 Innovir Laboratories, Inc. Regulatable nucleic acid therapeutic and methods of use thereof
US5663064A (en) * 1995-01-13 1997-09-02 University Of Vermont Ribozymes with RNA protein binding site
WO1998043993A2 (en) * 1997-03-31 1998-10-08 Yale University Nucleic acid catalysts
US6387703B1 (en) * 1997-10-07 2002-05-14 Smithkline Beecham Corporation Method for modulating gene expression
WO2000024912A1 (en) * 1998-10-23 2000-05-04 The Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression

Also Published As

Publication number Publication date
ZA200202823B (en) 2003-09-23
KR20020037384A (ko) 2002-05-18
HUP0203268A2 (hu) 2003-01-28
NO20021713D0 (no) 2002-04-11
WO2001029234A2 (en) 2001-04-26
NZ518396A (en) 2004-01-30
PL355165A1 (en) 2004-04-05
CA2387185A1 (en) 2001-04-26
NO20021713L (no) 2002-06-12
EP1224305A2 (en) 2002-07-24
CN1377414A (zh) 2002-10-30
CZ20021313A3 (cs) 2002-07-17
EP1092777A1 (en) 2001-04-18
HUP0203268A3 (en) 2005-08-29
AU784832B2 (en) 2006-07-06
IL148572A0 (en) 2002-09-12
AU1514901A (en) 2001-04-30
JP2003512059A (ja) 2003-04-02
WO2001029234A3 (en) 2001-11-29
BR0014632A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
AU7680300A (en) Human dna sequences
ZA200108291B (en) Diaminothiazoles and their use for inhibiting protein kinases.
GB0130301D0 (en) Control of gene expression
ZA982568B (en) The specificity of gene expression.
AU2001277653A1 (en) Diagnosis of known genetic parameters within the MHC
HUP0104825A3 (en) Genes and proteins, and their use
AUPQ659800A0 (en) Genetic sequences and uses therefor
ZA200204816B (en) Processes and organisms for the production of anti-freeze proteins.
AU2067501A (en) Human oxidoreductase proteins
MXPA02002864A (es) Secuencias de arn de auto- escision y su uso para el control de sintesis de proteinas.
GB2349150B (en) Expression of DNA or proteins in C. Elegans
WO2001098454A8 (en) Human dna sequences
AU1855001A (en) A new member of the pak protein family, nucleic acids and methods related to thesame
GB2362383B (en) Gene expression system
ZA200109120B (en) Use of Arylalkanoylpyridazines.
MXPA02002767A (es) Usos terapeuticos del polipeptido m3.
AU2001282132A1 (en) Isolation and sequencing of the pknb gene of c. glutamicum
AU2001236101A1 (en) Polypeptide having phosphodiesterase activity
AU2001295580A1 (en) Nucleotide sequences which code for the dep67 protein
GB9719359D0 (en) The Use of DNA Sequences
AU3364401A (en) Modified nucleic acids and their use
AUPP549898A0 (en) Genetic sequences and uses therefor
AU5524899A (en) Human deltex-like gene zdx
AU4494599A (en) Method for genetic engineering of disease resistance using the drr206 class of proteins
AU2001234150A1 (en) Novel protein and gene encoding the same

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: CENTELION

HC Change of company name or juridical status

Owner name: CENTELION

FA Abandonment or withdrawal